9 (32%) of the patients in group B and 11 (33%) of those in regimen C needed a second insulin injection. One episode of serious hypoglycaemia was observed.
Under regimen A:
fasting blood glucose fell from 14.5 (+/- 1.9) to 8.5 (+/- 2.0) P<0.05;
HbA(1c) decreased from 11.2 (+/- 1.3) to 8.2 (+/- 1.2%);
Body weight (kgs) rose from 67.4 (+/- 11.8) to 71.4 (+/- 12.8) P<0.05.
Under regimen B:
fasting blood glucose fell from 14.4 (+/- 1.9) to 8.4 (+/- 1.9) P<0.05;
HbA(1c) decreased from 10.5 (+/- 1.2) to 8.1 (+/- 1.1%);
Body weight (kgs) rose from 76.1 (+/- 16.4) to 80.5 (+/- 16.8) P<0.05.
Under regimen C:
fasting blood glucose fell from 13.5 (+/- 2.7) to 8.1 (+/- 2.2) P<0.05;
HbA(1c) decreased from 11.1 (+/- 1.3) to 8.5 (+/- 1.1%);
Body weight rose from 69.2 (+/- 10.3) to 72.6 (+/- 10.7) P<0.05.
The authors found no differences in the outcomes between regimens, but did not report the statistical significance of these findings.